Welltower Receives a Buy from Stephens

By Austin Angelo

In a report released yesterday, Dana Hambly from Stephens reiterated a Buy rating on Welltower (NYSE: WELL), with a price target of $64. The company’s shares closed yesterday at $61.70.

According to TipRanks.com, Hambly is a 4-star analyst with an average return of 9.4% and a 63.0% success rate. Hambly covers the Services sector, focusing on stocks such as Encompass Health Corporation, Addus Homecare Corp, and Envision Healthcare.

Currently, the analyst consensus on Welltower is a Moderate Buy with an average price target of $62.88, implying a 1.9% upside from current levels. In a report released yesterday, Stifel Nicolaus also reiterated a Buy rating on the stock with a $66 price target.


See today’s analyst top recommended stocks >>

Welltower’s market cap is currently $22.95B and has a P/E ratio of 156.08. The company has a Price to Book ratio of 1.66.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Welltower, Inc. operates as a real estate investment trust. It engages in investing with seniors housing operators, post acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.